Monocyte distribution width (MDW) as a reliable biomarker for urosepsis

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Addressing standardized definitions of post-COVID and long-COVID
4. Reviews
5. The chitinases as biomarkers in immune-mediate diseases
6. Pitfalls in the diagnosis of hematuria
7. Opinion Papers
8. Remote decentralized clinical trials: a new opportunity for laboratory medicine
9. Striving for a pragmatic contribution of biomarkers results to lifelong health care
10. IFCC Paper
11. External quality assessment practices in medical laboratories: an IFCC global survey of member societies
12. Guidelines and Recommendations
13. Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
14. General Clinical Chemistry and Laboratory Medicine
15. Evaluation of four automated clinical analyzers for the determination of total 25(OH)D in comparison to a certified LC-MS/MS
16. Standard −20 °C freezer storage protocols may cause substantial plasma renin cryoactivation
17. Lower accuracy of testosterone, cortisol, and free T4 measurements using automated immunoassays in people undergoing hemodialysis
18. Multicenter study to compare the diagnostic performance of CLIA vs. FEIA transglutaminase IgA assays for the diagnosis of celiac disease
19. Imprecision remains to be improved in the measurement of serum cystatin C with heterogeneous systems
20. Analytical validation of the modified Westergren method on the automated erythrocyte sedimentation rate analyzer CUBE 30 touch
21. Reference Values and Biological Variations
22. Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
23. Biological variation estimates for spot urine analytes and analyte/creatinine ratios in 33 healthy subjects
24. Short-term biological variation of plasma uracil in a Caucasian healthy population
25. Cardiovascular Diseases
26. Elevated Hemolysis Index is associated with higher risk of cardiovascular diseases
27. Infectious Diseases
28. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay
29. Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay
30. SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections
31. Monocyte distribution width alterations and cytokine storm are modulated by circulating histones
32. Letters to the Editor
33. Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205–212
34. Response to Tony Badrick regarding “Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205–212 by”
35. Monocyte distribution width (MDW) as a reliable biomarker for urosepsis
36. A consistency analysis of common biochemical tests in arterial blood and venous blood of critically ill patients
37. Test results comparison: is the S-Monovette^® Lithium-Heparin Gel+ a suitable replacement for the S-Monovette^® Lithium-Heparin Gel on Alinity Abbott^®?
38. Analytical performance of Abbott’s ARCHITECT and Alinity TSH-receptor antibody (TRAb) assays
39. Cis-AB showing discrepant results across different automated and manual methods: a case report and review of the literature
40. A graphical tool to investigate method validation
41. Live lab-monitor; a customizable HTML-based and systems independent, real-time laboratory overview screen
42. Congress Abstracts
43. 61st National Congress of the Hungarian Society of Laboratory Medicine
44. 9th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)